Lipopolysaccharide-Induced Tumor Necrosis Factor-alpha Factor (LITAF) Peptid
LITAF
Reaktivität: Human
Wirt: Synthetic
BP, BI
-
- Target Alle LITAF Produkte
- LITAF (Lipopolysaccharide-Induced Tumor Necrosis Factor-alpha Factor (LITAF))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- LITAF peptide corresponds to 14 amino acids of LITAF.
-
-
- Applikationshinweise
- LITAF Peptide is used for blocking the activity of LITAF antibody . The LITAF antibody ships at 0.5 mg/mL and the LITAF Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- LITAF peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- LITAF (Lipopolysaccharide-Induced Tumor Necrosis Factor-alpha Factor (LITAF))
- Synonyme
- PIG7 Peptide, SIMPLE Peptide, TP53I7 Peptide, EET-1 Peptide, Pig7 Peptide, TNF-alpha Peptide, 3222402J11Rik Peptide, C85531 Peptide, N4WBP3 Peptide, TBX1 Peptide, lipopolysaccharide induced TNF factor Peptide, lipopolysaccharide-induced TNF factor Peptide, LPS-induced TN factor Peptide, LITAF Peptide, Litaf Peptide
- Gen-ID
- 9516
- NCBI Accession
- NP_004853
- OMIM
- 65787265
- UniProt
- Q99732
-
Sie sind hier:
